ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2013
Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.
Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.PLoS medicine · 2014Pooled it
- The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.The American journal of gastroenterology · 2014Pooled it
- Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.Alimentary pharmacology & therapeutics · 2013Pooled it
- Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.Hepatology (Baltimore, Md.) · 2019Trial
- Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.Gastroenterology · 2017Trial
- Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.Journal of hepatology · 2022Article
- An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma.Journal of hepatocellular carcinoma · 2021Review
- Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.Digestive diseases and sciences · 2020Review
- Is hepatocellular carcinoma surveillance in high-risk populations effective?Hepatic oncology · 2020Review
- Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.Journal of gastrointestinal cancer · 2020Article
- A Telephone and Mail Outreach Program Successfully Increases Uptake of Hepatocellular Carcinoma Surveillance.Hepatology communications · 2020Article
- The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea.Gut and liver · 2020Article
- Surgical Delay Is Associated with Improved Survival in Hepatocellular Carcinoma: Results of the National Cancer Database.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019Article
- Hepatocellular carcinoma surveillance: An evidence-based approach.World journal of gastroenterology · 2019Review
- Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.Journal of clinical gastroenterology · 2017Article
- Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.Hepatology (Baltimore, Md.) · 2017Article
- Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.Journal of the National Cancer Institute · 2016Article
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2015Review
- How can we boost colorectal and hepatocellular cancer screening among underserved populations?Current gastroenterology reports · 2015Article
- Diagnostic delays are common among patients with hepatocellular carcinoma.Journal of the National Comprehensive Cancer Network : JNCCN · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Hepatocellular carcinoma (HCC) screening is a complex process, with failure at any step in the process contributing to a gap between its efficacy and effectiveness. Important lessons can be learned from colorectal cancer (CRC) screening studies to improve the HCC screening process in clinical practice. Lack of provider recommendations is a barrier for both CRC and HCC screening; however, under-recognition of at-risk individuals appears to be unique to HCC. Future HCC screening interventions should help providers identify at-risk patients as well as promote ordering of HCC screening among those with cirrhosis. Patient adherence, a well-recognized barrier to CRC screening, does not appear to be a major issue in HCC screening. Poor patient adherence may become an important factor in the future when upstream provider-level factors are addressed. Other steps in the screening process, including radiology capacity and timely follow-up, have been demonstrated as barriers for CRC screening but have yet to be assessed for HCC screening. Overall, many lessons learned from challenges to CRC screening can be applied to rapidly optimize HCC screening delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.